Related Experiment Video
Updated: Jan 6, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Analysis of Outcomes in Pancreaticoduodenectomy for Elderly Patients Aged 80 and Above: A Retrospective Study Using
Tianxiao Wang1, Yue Qiu2, Yingjixing Luo3
1Peking University China-Japan Friendship School of Clinical Medicine Beijing China.
Objectives:
With an aging population, more elderly individuals are facing the decision to undergo complex surgeries, such as pancreaticoduodenectomy (PD). This study evaluates the safety and feasibility of PD in patients aged 80 and above.
Methods:
We conducted a retrospective analysis of 422 patients who underwent PD between August 2011 and January 2024. The patients were categorized into three age groups: < 60 years, 60-79 years, and ≥ 80 years. We adjusted for baseline characteristics using inverse probability of treatment weighting (IPTW) and compared postoperative complications, hospital stay durations, 90-day mortality, and long-term survival across the groups. A subgroup analysis identified factors associated with complications and 90-day mortality.
Results:
After IPTW adjustment, no significant differences in complications or long-term survival were observed between the groups. However, the ≥ 80-year group had a significantly higher 90-day mortality rate (13.64%) compared to the 60-79 years group (2.00%) and the < 60 years group (1.46%) (p = 0.002). Subgroup analysis identified hypertension, coronary artery disease (CAD), and nutritional risk (NRS ≥ 3) as independent risk factors for complications, while age ≥ 80 and CAD were associated with higher 90-day mortality.
Conclusions:
Age does not significantly impact postoperative complications or long-term survival following PD. While PD is safe and feasible for the elderly, those with cardiovascular comorbidities or poor nutritional status face higher risks of complications and mortality. A comprehensive preoperative assessment is critical to minimizing these risks.
Related Concept Videos
Drug Dosing: Geriatric Patients
Chronic Pancreatitis II: Collaborative Care
Assessment:

